Erythrocyte ferritin in patients with chronic renal failure and heterozygous beta-thalassemia
Related Experiment Video
Updated: Aug 10, 2026
Measurement of Heme Synthesis Levels in Mammalian Cells
Published on: July 9, 2015
Vassiliki Christopoulou1, A Varsou, A Travlou
1Pathophysiology Department, Laiko General Hospital, University of Athens, 75 Mikras Asias Street, GR-115 27 Athens, Greece. ck@new-europe.gr
Aim:
The aim of this research is to study the variance of erythrocyte ferritin (EF) in patients with chronic renal failure (CRF) and heterozygous beta-thalassemia (beta-TA), as well as the use of EF as a more reliable index for assessing the body iron status.
Methods:
We studied 63 subjects with CRF, 40 subjects with heterozygous beta-TA, 53 subjects with CRF and heterozygous beta-TA and 24 normal subjects. In 11 patients with CRF and heterozygous beta-TA, sternal bone marrow aspiration was performed to evaluate iron stores in the bone marrow. EF was determined in the hemolysate of washed erythrocytes by a radioimmunoassay.
Results:
EF showed the strongest correlation with bone marrow iron (p < 0.001) in comparison with the remaining hematological parameters that were examined. Patients with CRF without heterozygous beta-TA showed an increase in serum ferritin (SF), even in cases of iron deficiency. In the group of heterozygous beta-TA without renal failure, 22.5% of patients showed an increased EF content up to 150 ag/cell and a tendency for iron overload. Patients with CRF and heterozygous beta-TA showed a high value of EF, up to 200 ag/cell, and iron overload in 22.6%, almost the same proportion as in the previous group. It was also observed that a high value of SF does not indicate iron overload for these patients. In the group of hemodialysis, patients without heterozygous beta-TA who were under erythropoietin (EPO) treatment presented iron deficiency. Many patients with CRF and heterozygous beta-TA who were taking EPO presented iron overload, while very few of them presented iron deficiency.
Conclusion:
These findings suggest that EF is a reliable index for assessing the iron status in patients with CRF and heterozygous beta-TA.
More Related Videos
05:23Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
11:59Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
Related Concept Videos
01:31Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
01:14Erythropoiesis
01:24Hemoglobin
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
01:22Lifecycle of Erythrocytes
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups.
01:27Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
01:24Factors Affecting Erythropoiesis
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...